[LXRX] YoY Quarter Result on 31-Dec-2013 [#Q4]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
07-Mar-2014
Financial Year
2013
Quarter
31-Dec-2013 [#Q4]
Profit Trend
QoQ- 44.99%
YoY- 29.99%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Revenue 23,037 127,280 21,482 1,410 218 343 1,253 62.38%
PBT -32,419 86,750 -3,003 -17,414 -24,873 -33,845 -22,999 5.88%
Tax 37 1,612 -70 -174 -55,799 -56,267 26 6.05%
NP -32,419 86,750 -2,933 -17,414 -24,873 -33,845 -22,999 5.88%
Tax Rate - -1.86% - - - - - -
Total Cost 55,456 40,530 24,415 18,824 25,091 34,188 24,252 14.76%
Ratio Analysis
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
NP Margin -140.73 68.16 -13.65 -1,235.04 -11,409.63 -9,867.35 -1,835.51 -34.79%
Per Share
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
EPS -0.31 0.84 -0.03 -0.24 -0.34 -0.49 -0.48 -7.02%
EPS Diluted -0.31 0.76 -0.03 -0.24 -0.34 -0.49 -0.48 -7.02%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.